Drugs News and Research

RSS

First Edition: December 17, 2013

Today's headlines include reports about how the health law is viewed by immigrant populations.

17 Dec 2013

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Amneal Pharmaceuticals LLC today announced the launch of its branded Esomeprazole Strontium 49.3 mg delayed-release capsules. Esomeprazole Strontium contains the same active moiety (esomeprazole) in a different salt form as found in the branded proton-pump inhibitor Nexium (esomeprazole magnesium) and is a new option for adult patients for the short term treatment of gastroesophageal reflux disease.

17 Dec 2013

Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leukemia

BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia, was presented in a poster at the Annual Meeting of the American Society of Hematology, which took place on December 7-10, 2013.

17 Dec 2013

Ipsen reports positive initial results from Dysport phase III study in Adult Upper Limb spasticity

Ipsen today announced positive initial results from the double-blind phase III study of Dysport (abobotulinumtoxinA) in Adult Upper Limb spasticity. Regarding the primary endpoints, treatment with Dysport showed statistically significant response versus placebo in the improvement of muscle tone, as measured by the Modified Ashworth Scale.

17 Dec 2013

Biogen joins with Samsung Bioepis to commercialize anti-TNF biosimilar product candidates in Europe

Biogen Idec (NASDAQ: BIIB) and Samsung Bioepis today announced that through their joint venture, Biogen Idec has exercised its right to enter into an agreement to commercialize anti-TNF biosimilar product candidates in Europe, including biosimilars for widely used therapies to treat conditions such as rheumatoid arthritis and Crohn's disease.

17 Dec 2013

Viewpoints: Health law still facing major challenges; Ky. gov. questions McConnell's assessment of overhaul; Pa.'s Medicaid experiment is a 'sham'

The White House is claiming that the Healthcare.gov website is mostly fixed, that the millions of Americans whose health plans were canceled thanks to government rules may be able to keep them for another year, and that in any event these people will get better plans through ObamaCare exchanges. Whatever the truth of these assertions, those who expect better days ahead for the Affordable Care Act are in for a rude awakening. The shocks - economic and political - will get much worse next year and beyond (Michael J. Boskin, 12/15).

17 Dec 2013

Two existing drugs show promise as potential treatments for cervical cancer

Two existing drugs - one the active ingredient in an anti-fungal medication and the other now used to control iron levels in the blood - both show promise as potential treatments for cervical cancer, according to newly published research by scientists at Rutgers New Jersey Medical School.

17 Dec 2013

Individuals still getting errors from health website as notifications to insurers lag

The Wall Street Journal looks at some of the inaccurate assignments that many consumers find when they seek insurance on the new marketplaces. Meanwhile, the enrollment records for 15,000 people were not properly transmitted to insurance plans, according to federal officials.

17 Dec 2013

Scientists continue work to end chemotherapy pain

With this year's $600,000 grant from the Leukemia & Lymphoma Society and $1.5 million grant from the NIH, a Saint Louis University investigator is continuing her work to end chemotherapy pain. Noted pain researcher Daniela Salvemini, Ph.D., is using the funding to capitalize on her recent finding published in Pain, a breakthrough that helps scientists understand a molecular pathway by which pain occurs with certain anti-cancer drugs.

17 Dec 2013

Study: Health care costs increase in parallel with body mass measurements

Researchers at Duke Medicine are giving people another reason to lose weight in the new year: obesity-related illnesses are expensive. According to a study published in the journal Obesity, health care costs increase in parallel with body mass measurements, even beginning at a recommended healthy weight.

17 Dec 2013

Scientists find vaccine that blocks invasion of blood cell by Malaria parasite

Scientists from Singapore's Nanyang Technological University (NTU) have discovered a key process during the invasion of the blood cell by the Malaria parasite, and more importantly, found a way to block this invasion.

16 Dec 2013

BWH receives $140M grant from NIAID to support ongoing research led by AIDS Clinical Trial Group

The National Institute of Allergy and Infectious Diseases has awarded two seven-year grants to Brigham and Women's Hospital to fund the AIDS Clinical Trial Group Network.

16 Dec 2013

Dysfunction of retinoblastoma enables inhibitory protein to promote pancreatic cancer growth

Indiana University cancer researchers have discovered that a protein that normally suppresses tumors actually promotes the growth and spread of pancreatic cancer.

16 Dec 2013

Study: Blue light proves to have powerful bacteria-killing ability

Blue light has proven to have powerful bacteria-killing ability in the laboratory. The potent antibacterial effects of irradiation using light in the blue spectra have now also been demonstrated in human and animal tissues. A series of groundbreaking articles that provide compelling evidence of this effect are published in Photomedicine and Laser Surgery, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers.

16 Dec 2013

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).

16 Dec 2013

Medical Daily announces marketing and distribution partnership with UBM Medica US

Medical Daily announced today a unique marketing and distribution partnership with UBM Medica US. Medical Daily is a source of breaking health news, scientific trends and innovations.

16 Dec 2013

First Edition: December 16, 2013

Today's headlines include findings from an Associated Press poll probing Americans thoughts about the health law.

16 Dec 2013

Viewpoints: States need to expand Medicaid to benefit all; lies about immigrants and doctors; antibiotics and animals

Expanding Medicaid costs states a pittance compared with the financial and social benefits they'll receive. Denying your constituents a chance to get health insurance out of political pique comes perilously close to governmental malpractice.

16 Dec 2013

Drug abuse appears to foster brain changes that resemble schizophrenia

Teens who were heavy marijuana users -- smoking it daily for about three years -- had abnormal changes in their brain structures related to working memory and performed poorly on memory tasks, reports a new Northwestern Medicine- study.

16 Dec 2013

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in the EU, today announced that its partner Auxilium Pharmaceuticals, Inc. has dosed the first patient in its Phase 2b study of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome (adhesive capsulitis).

16 Dec 2013

Drugs News and Research

First Edition: December 17, 2013

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leukemia

Ipsen reports positive initial results from Dysport phase III study in Adult Upper Limb spasticity

Biogen joins with Samsung Bioepis to commercialize anti-TNF biosimilar product candidates in Europe

Viewpoints: Health law still facing major challenges; Ky. gov. questions McConnell's assessment of overhaul; Pa.'s Medicaid experiment is a 'sham'

Two existing drugs show promise as potential treatments for cervical cancer

Individuals still getting errors from health website as notifications to insurers lag

Scientists continue work to end chemotherapy pain

Study: Health care costs increase in parallel with body mass measurements

Scientists find vaccine that blocks invasion of blood cell by Malaria parasite

BWH receives $140M grant from NIAID to support ongoing research led by AIDS Clinical Trial Group

Dysfunction of retinoblastoma enables inhibitory protein to promote pancreatic cancer growth

Study: Blue light proves to have powerful bacteria-killing ability

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

Medical Daily announces marketing and distribution partnership with UBM Medica US

First Edition: December 16, 2013

Viewpoints: States need to expand Medicaid to benefit all; lies about immigrants and doctors; antibiotics and animals

Drug abuse appears to foster brain changes that resemble schizophrenia

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News